Acura Pharmaceuticals, Inc.

Acura Pharmaceuticals reports loss of $0.01 per share

Published in Lab Business Week, June 11th, 2006

Acura Pharmaceuticals, Inc., (OTC.BB - ACUR) announced a net loss of $4.2 million or $0.01 per share for the quarter ending March 31, 2006 compared to a net loss of $1.9 million or $0.09 per share for the same period in 2005.

Included in the 2006 and 2005 results is a non cash compensation charge of $2.8 million and $0.4 million, respectively, for stock compensation expense pertaining to the company's issued and outstanding stock options and restricted stock units. Highlights of the company's consolidated balance sheets and statements of operations appear below. Detailed financial statements are included in the company's Form 10-Q for the quarter ended March 31, 2006...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2006-06-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry